Clinical Trials Browser

Phase 2 × Receptors, Chimeric Antigen × 30 days × Clear all

NCT05757219 2026-02-27

Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse